Evidence map›Paper›PMID 28275164›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2017

Plasminogen Deficiency Delays the Onset and Protects from Demyelination and Paralysis in Autoimmune Neuroinflammatory Disease.

Maureen A Shaw, Zhen Gao, Kathryn E McElhinney, Sherry Thornton, Matthew J Flick, Adam Lane, Jay L Degen, Jae Kyu Ryu, Katerina Akassoglou, Eric S Mullins

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. siRNA-mediated reduction of a circulating protein in swine using lipid nanoparticles.Molecular therapy. Methods & clinical development · 2024
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Using antifibrinolytics to tackle neuroinflammation.Neural regeneration research · 2020
    Review
  16. Article
  17. Article
  18. A critical role for plasminogen in inflammation.The Journal of experimental medicine · 2020
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Maureen A ShawDivisions of Hematology.
Zhen GaoDivisions of Hematology.
Kathryn E McElhinneyDivisions of Hematology.
Sherry ThorntonDivision of Rheumatology, Cincinnati Children's Research Foundation, Cincinnati Children's Hospital, Cincinnati, Ohio 45229.
Matthew J FlickExperimental Hematology and Cancer Biology, and.
Adam LaneBone Marrow Transplantation and Immune Deficiency, Cancer and Blood Diseases Institute, and.
Jay L DegenExperimental Hematology and Cancer Biology, and.
Jae Kyu RyuNeurological Disease, Gladstone Institutes, San Francisco, California 94158, and.
Katerina AkassoglouNeurological Disease, Gladstone Institutes, San Francisco, California 94158, and.
Eric S MullinsDivisions of Hematology, eric.mullins@cchmc.org.
Laboratoire d’immunologie intégrative du cancer · FRCincinnati Children's Hospital Medical Center · USGladstone Institutes · USUniversity of California, San Francisco · US

Funding

Neurovascular Interactions: Mechanisms, imaging, therapeutic potentialR35NS097976 · NINDS · J. DAVID GLADSTONE INSTITUTES · PI AKASSOGLOU, KATERINA · 2016 to 2023
$11.1M
Tissue Repository CoreP30AR070549 · NIAMS · CINCINNATI CHILDRENS HOSP MED CTR · PI SHERRY L THORNTON · 2016 to 2026
$7.7M
Hemostatic factors and sickle cell diseaseR01HL112603 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI FLICK, MATTHEW J., MALIK, PUNAM · 2012 to 2016
$1.9M
Mechanisms Linking Hemostatic Facotrs to Neuroinflammatory DiseaseK08HL105672 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI MULLINS, ERIC S · 2011 to 2015
$655k
NHLBI NIH HHS K08 HL105672NHLBI NIH HHS R01 HL112603NIAMS NIH HHS P30 AR070549NINDS NIH HHS R35 NS097976
6 · The paper itself

Abstract

Multiple sclerosis (MS) is a neuroinflammatory, demyelinating disease of the CNS. Fibrinogen deposition at sites of blood-brain barrier breakdown is a prominent feature of neuroinflammatory disease and contributes to disease severity. Plasminogen, the primary fibrinolytic enzyme, also modifies inflammatory processes. We used a murine model of MS, experimental autoimmune encephalomyelitis (EAE), to evaluate the hypothesis that the loss of plasminogen would exacerbate neuroinflammatory disease. However, contrary to initial expectations, EAE-challenged plasminogen-deficient (Plg

Indexed as

AnimalsCells, CulturedDemyelinating DiseasesEncephalomyelitis, Autoimmune, ExperimentalFemaleMiceMice, Inbred C57BLMice, KnockoutParalysisPlasminogenPlasminogenfibrinogenfibrinolysismiceneuroinflammationplasminogen

Identifiers

PMID28275164
PMCPMC5394895
OpenAlexW2594604656

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.